Wordt geladen...
Plasma Cannabinoid Pharmacokinetics following Controlled Oral Δ(9)-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
BACKGROUND: Sativex(®), a cannabis extract oromucosal spray containing Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD), is currently in phase III trials as an adjunct to opioids for cancer pain treatment, and recently received United Kingdom approval for treatment of spasticity. There are indi...
Bewaard in:
Hoofdauteurs: | , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2010
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3717338/ https://ncbi.nlm.nih.gov/pubmed/21078841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1373/clinchem.2010.152439 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|